BMJ InstructionsForAuthors 05.2018
BMJ InstructionsForAuthors 05.2018
BMJ InstructionsForAuthors 05.2018
archive. The BMJ occasionally publishes as open access other 4.0) license, which permits others to distribute, remix, adapt,
types of (non—research) articles arising from work funded by build upon this work non-commercially, and license their
a funder who mandates open access publication. derivative works on different terms, provided the original work
is properly cited and the use is non-commercial. See: http://
All Research articles published by The BMJ are published creativecommons.org/licenses/by-nc/4.0.”
by default as open access (irrespective of who funded the
research). Any other article based on work funded by a fund- • CC BY — articles funded by certain organisations (currently
ing organisation that requires open access publication—that RCUK and the Wellcome Trust) that mandate publication
is, requires its grant recipients to deposit publications arising with a Creative Commons Attribution (CC BY 4.0) licence are
out of the funded work to be deposited in PubMed Central published with this licence. CC BY 4.0 permits reuse for com-
open access repository - can also be published as such. We mercial purposes subject to the article being fully attributed
offer two types of open access license:
CC BY articles can be identified by the following statement
• CC BY-NC — by default, we publish our Open Access that appears at the end of the article:
articles under a Creative Commons Attribution Non “This is an open access article distributed in accordance with
Commercial (CC BY-NC 4.0). CC BY-NC articles allow the terms of the Creative Commons Attribution (CC BY 4.0)
the author, and any non-commercial bodies, to reuse license, which permits others to distribute, remix, adapt and
the material in any way they choose, without acquiring build upon this work, for commercial use, provided the origi-
permission from BMJ. Any reuse must give attribution to the nal work is properly cited. See: http://creativecommons.org/
author, usually by including a reference. Commercial users licenses/by/4.0.”For additional information, please see the
will require permission from BMJ for any reuse. section of instructions to authors on copyright, open access,
and permission to reuse.
CC BY-NC articles can be identified by the following state-
ment that appears at the end of the article: 2. ARTICLE TYPES AT THE BMJ
“This is an open access article distributed in accordance with At The BMJ, we offer the opportunity to submit a range of
the Creative Commons Attribution Non Commercial (CC BY-NC article types, each with different requirements. Before sub-
mitting any work to The BMJ, we encourage all authors to
Article types at The BMJ
explore our advice on these article types to ensure that work
Section Form information
is framed in the best possible way for review and publication.
Research Original research studies that can improve decision making in clinical medicine, public health,
health care policy, medical education, or biomedical research. You can find out more about our main article type, as well
as access examples of previously published articles in the
Research Methods RMR articles discuss the nuts and bolts of doing and writing up research and are aimed at table to the left.
and Reporting doctors who are interested in doing and interpreting clinical research. We also consider
(RMR) papers that present new or updated research reporting guidelines.
3. PREPARING YOUR ARTICLE
Analysis Analysis papers address topical clinical, scientific, ethical, and policy issues that matter
to doctors, patients and health policy makers. These articles present a clearly reasoned 3.1 Requirements for ALL manuscripts
argument, are backed by an even—handed look at the evidence, and have a clear key Please ensure that anything you submit to The BMJ conforms
message. Articles that set out hypotheses are not suitable unless they contain a convincing to the International Committee of Medical Journal Editors’
attempt to test them.
(ICMJE) Recommendations for the Conduct, Reporting,
Education These deal with topics and conditions that are common or have serious consequences, have Editing, and Publication of Scholarly work in Medical
international appeal, and may interest doctors from different specialties and backgrounds. We Journals uniform recommendations for manuscripts sub-
commission all our education content (sometimes after a potential author pitches us the idea)
mitted to biomedical journals. Before submitting an article,
and do not accept unsolicited submissions for this section.
please ensure that you have followed all guidelines below.
Editorials These are usually commissioned. We are, however, happy to consider and peer review
unsolicited editorials. Please remember that the primary audience for our editorials comprises Further details about The BMJ’s stance on authorship, con-
generalists, including general practitioners. We are keen to consider editorials, or ideas for
editorials, from authors outside the UK.
tributorship and group authorship can be found on our
Authorship and contributorship page.
Personal Views These are highly readable and compelling commentaries that appeals to our international
readership of practising doctors. 3.2 Title page and authorship
The title should be informative and, for research papers, a
BMJ Opinion Comment and opinion blogs about medicine, healthcare and publishing written by The BMJ’s
international community of readers, authors, and editors. subtitle with the study design (for example, “phase III clini-
cal trial” or “systematic review and meta—analysis”).
BMJ Careers These articles discuss issues related to medical careers.
On this page, please provide for each author his or her name,
Rapid Responses These are electronic letters to the editor that are related to manuscripts published in The BMJ.
Anyone can respond without a subscription to any article published on The BMJ by sending a
affiliation (job title) at the time the paper was written, email
rapid response. Our weekly published letters are edited selections of posted rapid responses and, for the corresponding author, the best contact address.
and are indexed in PubMed. Rapid responses are not indexed in PubMed but they have their All authors must fulfill the ICMJE criteria for authorship. If
own URL and are retrievable in an advanced search of bmj.com in perpetuity.
the number of authors is very large we may ask for confirma-
Christmas Issue We publish a special two—week issue of The BMJ over Christmas and New Year. We are
tion that everyone listed met the ICMJE criteria for author-
pleased to consider all kinds of articles, including reports of original research, for this issue ship. We also offer the option of joint first authorship when
and particularly welcome colour illustrations. All submissions should follow the standard two authors meet criteria for such a designation. We reserve
requirements for The BMJ’s articles and should be submitted by the annual deadline, which
usually falls in early September. Further details can be found online here.
the right to require that authors form a group whose name
will appear in the article byline. MEDLINE guidance explains
ORCID IDs that group authorship is acceptable, stating “When a group from us. Only if the use is commercial do we need to know
Open Researcher and Contributor ID name for a specific consortium, committee, study group, or about it. In addition, we will pay authors a royalty on certain
(ORCID) is a non-profit organization
the like appears in an article byline, the personal names of commercial uses that we negotiate.
creating a central registry of unique
identifiers for individual researchers the members of that group may be published in the article Information on permissions for authors and third parties for
and an open, transparent linking text. Such names are entered as collaborator names for the reuse can be found here.
mechanism between ORCID and
MEDLINE citation.”
other current author identifier
schemes. Manuscripts authored or coauthored by one or more National
3.3 Contributor and guarantor information Institutes of Health (NIH) employees must be submitted
We strongly encourage all authors Contributorship statements should make clear who has with a completed and signed NIH Publishing Agreement
to register for an ORCID profile. To
contributed what to the planning, conduct, and reporting of and Manuscript Cover Sheet according to NIH’s Employee
learn more about ORCID, please
visit http://orcid.org/content/ the work described in the article, and should identify one, or Procedures.
initiative occasionally more, contributor(s) as being responsible for the
overall content as guarantor(s). The guarantor accepts full 3.5 Patient consent (if applicable)
responsibility for the work and/or the conduct of the study, Publication of any personal information about a patient
had access to the data, and controlled the decision to pub- in The BMJ — for example, in a case report or clinical pho-
BMJ house style and image
usage guidelines lish. Specific contributions are determined by the authors tograph — will normally require the signed consent of the
Learn about our house writing themselves - we do not have a specific taxonomy on contri- patient. If this is the case, please include a statement that
style butions. For articles in The BMJ that do not report original any identifiable patients have provided their signed consent
Find out more about incorporating
research — such as editorials, clinical reviews, and education to publication and submit as a supplemental file.
images into your submission
and debate — please state who had the idea for the article,
who performed the literature search, who wrote the article, 3.6 Competing interests declaration
and who is the guarantor (the contributor who accepts full A competing interest — often called a conflict of interest —
BMJ patient consent forms
responsibility for the finished article, had access to any data, exists when professional judgment concerning a primary
Our consent forms are available in
multiple languages at this page. and controlled the decision to publish). For non—research interest (such as patients’ welfare or the validity of research)
articles that include case reports such as lessons of the week, may be influenced by a secondary interest (such as financial
drug points, and interactive case reports, please also state gain, academic promotion, or personal rivalry). It may arise
who identified and/or managed the case(s). We encourage for the authors of an article when they have a financial inter-
authors to fully acknowledge the contribution of patients and est that may influence, probably without their knowing, their
the public to their research where appropriate. interpretation of their results or those of others.
3.4 Copyright/licence for publication We believe that to make the best decision on how to deal
Since January 2000, The BMJ has not asked authors of with an article, we should know about any competing inter-
journal articles to assign us their copyright and authors ests that authors may have, and that if we publish the article
(or their employers) retain their copyright in the article. All readers should know about them too. We are not aiming to
we require from authors is an exclusive licence (or, from eradicate such interests across all article types in The BMJ.
government employees who cannot grant this, a non— However, certain articles (see below) fall under a stricter
exclusive licence) that allows us to publish the article in policy announced in 2014. This means that authors whose
The BMJ (including any derivative products) and any other financial conflicts of interest are judged to be relevant by
BMJ products (such as overseas editions), and allows us the BMJ team are not permitted to write these articles. We
to sublicence such rights and exploit all subsidiary rights. also ask our staff and reviewers to declare any competing
interests.
For non-research articles, we ask the corresponding author
to grant this exclusive licence (or non—exclusive for govern- A declaration of interests for all authors must be received
ment employees) on behalf of all authors by reading our before an article can be reviewed and accepted for pub-
licence and inserting in the manuscript on submission the lication. It should take one of two forms, depending on
following statement: what type of article you are submitting, detailed on the
following page.
“The Corresponding Author has the right to grant on behalf of
all authors and does grant on behalf of all authors, a world- 4. ADDITIONAL REQUIREMENTS BY ARTICLE TYPE
wide licence to the Publishers and its licencees in perpetuity, In addition to the above, all of our articles have additional
in all forms, formats and media (whether known now or cre- requirements which should be fulfilled before submitting.
ated in the future), to i) publish, reproduce, distribute, display For more information on any of the requirements below,
and store the Contribution, ii) translate the Contribution into please contact papersadmin@bmj.com.
other languages, create adaptations, reprints, include within
collections and create summaries, extracts and/or, abstracts of 4.1 RESEARCH
the Contribution, iii) create any other derivative work(s) based 4.1.1 What kind of research does The BMJ publish?
on the Contribution, iv) to exploit all subsidiary rights in the The BMJ gives priority to articles reporting original,
Contribution, v) the inclusion of electronic links from the Con- robust research studies that can improve decision making
tribution to third party material where—ever it may be located; in medical practice, policy, education, or future research
and, vi) licence any third party to do any or all of the above.” and will be important to general medical readers inter-
This licence allows authors to use their own articles for their nationally.
own non—commercial purposes without seeking permission
All authors must review the updated COI policy and complete The BMJ’s Education
Declaration of Interests form. If the article is accepted for publication these completed forms
will be stored and made available on request. The corresponding author should insert within
their manuscript a summary statement derived from the information provided in the COI
forms (link below): “I/We have read and understood BMJ policy on declaration of interests and
declare the following interests: [list them or state that you have none].”
Research and RMR We ask authors of research papers to use a revised version of the ICMJE’s unified disclosure • No competing interests: “All authors have completed the ICMJE uniform
articles form. The unified form can be used for several journals. Each journal, will, however, integrate disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no
the form into its processes in different ways. support from any organisation for the submitted work; no financial
relationships with any organisations that might have an interest in the
Authors must disclose three types of information: submitted work in the previous three years; no other relationships or
• Associations with commercial entities that provided support for the work reported in activities that could appear to have influenced the submitted work.”
the submitted manuscript (the timeframe for disclosure in this section of the form is the • Grant funding for research but no other competing interest: “All authors
lifespan of the work being reported). have completed the ICMJE uniform disclosure form at www.icmje.org/
• Associations with commercial entities that could be viewed as having an interest in the coi_disclosure.pdf and declare: all authors had financial support from
general area of the submitted manuscript (in the three years before submission of the ABC Company for the submitted work; no financial relationships with
manuscript). any organisations that might have an interest in the submitted work in
• Non—financial associations that may be relevant or seen as relevant to the submitted the previous three years; no other relationships or activities that could
manuscript. appear to have influenced the submitted work.”
• Mixed competing interests: “All authors have completed the ICMJE
All authors must complete the disclosure form and send it to the corresponding author uniform disclosure form at www.icmje.org/coi_disclosure.pdf and
who will use the information in the forms to craft the COI statement for the paper (examples declare: no support from any organisation for the submitted work; AB
provided below). The statement but not the forms must be included with the submission. and has received research grants and honorariums from XYZ company, BF
that must be included with the initial submission. If the paper is accepted, these forms will be has been paid for developing and delivering educational presentations
required and will be published alongside the article. for BBB foundation, DF does consultancy for HHH and VVV companies;
no other relationships or activities that could appear to have influenced
The statement in the manuscript should take the following format: the submitted work.”
“Competing interests: All authors have completed the ICMJE uniform disclosure form at
www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the
submitted work [or describe if any]; no financial relationships with any organisations that
might have an interest in the submitted work in the previous three years [or describe if any]; no
other relationships or activities that could appear to have influenced the submitted work [or
describe if any].”
All other articles Complete The BMJ’s Disclosure form. We do not need to receive signed copies of the statements regarding competing interests or the licence to publication: these are for
information only. When submitting your article (or a revised version of it) you will be prompted at our online editorial office to tick two boxes , confirming that you have read and
complied with our policies on competing interests and licence to publication. Please also ensure that your manuscript, whether in original or revised form, also includes your
written statements of competing interests and licence to publication.
The BMJ welcomes studies that will aid the translation of count for the main text (excluding the abstract, references,
knowledge and implementation of evidence into practice tables, boxes, or figures) when you submit your manuscript.
and policy, and is particularly interested in evaluations
of the comparative effectiveness of interventions. This Original research articles should follow the IMRaD style
knowledge may be most relevant to the day to day deci- (introduction, methods, results, and discussion) and should
sions doctors make with patients, to public health, or to include a structured abstract (see below), a structured dis-
policy decisions about healthcare. cussion, and a succinct introduction that focuses — in no
To learn more about the kind of research articles we more than three paragraphs — on the background to the
give priority to, and what services we offer to authors research question.
of research, please read the editorial “Publishing your
research study in the BMJ?”. Please note that we wel- For an intervention study, the manuscript should include
come studies — even with “negative” results — as long enough information about the intervention(s) and
as their research questions are important, new, and rel- comparator(s) (even if this was usual care) for reviewers
evant to general readers and their designs are appropri- and readers to understand fully what happened in
ate and robust. the study. To enable readers to replicate your work or
implement the interventions in their own practice,
Word count and style please also provide any relevant detailed descriptions
To encourage full and transparent reporting of research we and materials (uploaded as one or more supplemental
do not set fixed word count limits for research articles. None- files, including video and audio files where appropriate).
theless, we ask you to make your article concise and make Alternatively, please provide URLs to openly accessible
every word count. You will be prompted to provide the word websites where these materials can be found.
Please ensure that the discussion section of your article avoid “we did” or “we found”. Numbers over 10 do
comprises no more than a page and a half and follows this not need spelling out at the start of sentences. P values
overall structure, with subheadings: should always be accompanied by supporting data, and
denominators should be given for percentages. Confidence
• Statement of principal findings intervals should be written in the format (15 to 27) within
• Strengths and weaknesses of the study parentheses, using the word “to” rather than a hyphen.
• Strengths and weaknesses in relation to other studies, Abstracts do not need references.
discussing important differences in results
• Meaning of the study: possible explanations and Statistical issues
implications for clinicians and policymakers We want your piece to be easy to read but also as
• Unanswered questions and future research scientifically accurate as possible. We encourage authors
to review the “Statistical Analyses and Methods in the
Structured abstract Published Literature or The SAMPL Guidelines” while
Please ensure that the structured abstract is as complete, preparing their manuscript.
accurate, and clear as possible and has been approved by
all authors. We may screen original research articles by Whenever possible, state absolute rather than relative risks.
Submitting a BMJ Research
reading only the abstract.
article
All BMJ Research articles should be Please include in the results section of your structured
submitted through our submission Abstracts should be 250— 300 words long: you may need abstract (and in the article’s results section) the following
system at submit.bmj.com up to 400 words, however, for a CONSORT or PRISMA terms, as appropriate:
Completed ICMJE forms are
style abstract. MEDLINE can now handle up to 600 words.
required for ALL Research authors
Abstracts should include the following headings, but they For a clinical trial:
may be modified for abstracts of clinical trials or systematic • Absolute event rates among experimental and control
reviews and meta—analyses according to the requirements groups.
on the the CONSORT extension for abstracts and the • RRR (relative risk reduction).
PRISMA extension for abstracts, respectively. • NNT or NNH (number needed to treat or harm) and its
Research article checklist
We have produced a checklist
95% confidence interval (or, if the trial is of a public health
on bmj.com to help you decide • Objectives — a clear statement of the main aim of the study intervention, number helped per 1000 or 100,000).
whether The BMJ is the right journal and the major hypothesis tested or research question posed
for your work.
• Design — including factors such as prospective, For a cohort study:
Another resource, the Authors’
Submission Toolkit: A practical randomisation, blinding, placebo control, case control, • Absolute event rates over time (eg 10 years) among
guide to getting your research crossover, criterion standards for diagnostic tests, etc. exposed and non—exposed groups
published, summarises general • Setting — include the level of care, eg primary, • RRR (relative risk reduction)
tips and best practices to increase
awareness of journals’ editorial secondary; number of participating centres. Be general
requirements, how to choose rather than give the name of the specific centre, but For a case control study:
the right journal, submission give the geographical location if this is important • OR (odds ratio) for strength of association between
processes, publication ethics,
peer review, and effective • Participants (instead of patients or subjects) — exposure and outcome
communication with editors. numbers entering and completing the study, sex, and
If your work does not seem to ethnic group if appropriate. Give clear definitions For a study of a diagnostic test:
fit in The BMJ you may prefer to
of how selected, entry and exclusion criteria. • Sensitivity and specificity
try another journal with a more
specialist or local readership, or a • Interventions — what, how, when and for how long. This • PPV and NPV (positive and negative predictive values)
higher acceptance rate. heading can be deleted if there were no interventions but
should normally be included for randomised controlled The box stating what is known and what this study adds
trials, crossover trials, and before and after studies. (see below) should also reflect accurately the above
• Main outcome measures — those planned in the information. Under what this study adds, please give the
protocol, those finally measured (if different, explain why). one most useful summary statistic eg NNT.
• Results — main results with (for quantitative
studies) 95% confidence intervals and, where Please do not use the term ‘negative’ to describe studies that
appropriate, the exact level of statistical significance have not found statistically significant differences, perhaps
and the number need to treat/harm. Whenever because they were too small. There will always be some
possible, state absolute rather than relative risks. uncertainty, and we hope you will be as explicit as possible
• Conclusions — primary conclusions and their in reporting what you have found in your study. Using
implications, suggesting areas for further research wording such as “our results are compatible with a decrease
if appropriate. Do not go beyond the data in of this much or an increase of this much” or ‘this study
the article. Conclusions are important because found no effect’ is more accurate and helpful to readers
this is often the only part that readers look at. than “there was no effect/no difference.” Please use such
• Trial registration — registry and number (for clinical wording throughout the article, including the structured
trials and, if available, for observational studies and abstract and the box stating what the paper adds.
systematic reviews).
Provide one or more references for the statistical package(s)
When writing your abstract, use the active voice but used to analyse the data — for example, RevMan for a
systematic review. There is no need to provide a formal we would like to know if results have been posted, and
reference for a very widely used package that will be familiar where (please provide URLs or trial registration details).
to general readers — for example, Stata — but please say in We require protocols for clinical trials that have now been
the text which version you used. published. We are pleased to consider articles based on
longer systematic reviews and meta—analyses published at
Reporting checklists and guidelines the Cochrane Library or HTA database.
Download recommended Reporting guidelines promote clear reporting of methods
reporting guidelines directly
and results to allow critical appraisal of the manuscript. • In most cases, we will follow suggestions for preferred
All reporting guidelines
recommended here are available We ask that all manuscripts be written in accordance with and non—preferred reviewers. If you have suggestions for
for full download from our the appropriate reporting guideline. Please submit as preferred reviewers, please provide us with their names
Instructions for Authors page. supplemental material the appropriate reporting guideline and contact details; we may invite some of them to review
checklist showing on which page of your manuscript each the paper. Please also let us know if you would not like us to
checklist item appears. A complete list of guidelines can be invite specific reviewers to look at your work but provide an
found in the website of the Equator Network. Below is the explanation for your request.
list of most often used checklists but others may apply.
• Assurance that a study funded or sponsored by industry
follows the guidelines on good publication practice.
RECOMMENDED REPORTING GUIDELINES
These GPP2 guidelines aim to ensure that such studies
Clinical trials: For a clinical trials, use the CONSORT are published in a responsible and ethical manner. The
checklist and also include a structured abstract that
guidelines cover companies’ responsibility to endeavour
follows the CONSORT extension for abstract checklist,
the CONSORT flowchart and, where applicable, the to publish results of all studies, companies’ relations with
appropriate CONSORT extension statements (for example, investigators, measures to prevent redundant or premature
for cluster RCTs, pragmatic trials, etc.). A completed publication, the roles of authors and contributors, and the
TIDieR checklist is also helpful as this helps to ensure role of professional medical writers.
that trial interventions are fully described in ways that
are reproducible, usable by other clinicians, and clear • Assurance that any article written by a professional
enough for systematic reviewers and guideline writers.
medical writer follows the guidelines by the European
Medical Writers’ Association on the role of professional
Systematic reviews and meta—analysis: For systematic
reviews or meta—analysis of randomised trials and medical writers. The guidelines emphasise the importance
other evaluation studies, use the PRISMA checklist and of respecting widely recognised authorship criteria, and
flowchart and use the PRISMA structured abstract checklist in particular of ensuring that all people listed as named
when writing the structured abstract. authors have full control of the content of articles. The
role of professional medical writers must be transparent.
Diagnostic accuracy: STARD checklist and flowchart Please name any professional medical writer among the
Observational studies: For observational studies, use the list of contributors to any article for The BMJ (not only
STROBE checklist and any appropriate extension STROBE original research articles), and specify in the formal funding
extensions.
statement for the article who paid the writer. Writers and
Genetic risk prediction: GRIPS guidelines.
authors must have access to relevant data while writing
Economic evaluation studies: CHEERS guidelines. articles. Medical writers have professional responsibilities
Prediction models: For studies developing, validating or to ensure that the articles they write are scientifically valid
updating a prediction model, use TRIPOD.
and are written in accordance with generally accepted
ethical standards.
For articles that include explicit statements of the quality
of evidence and strength of recommendations, we prefer
reporting using the GRADE system. Additional information that must be included with reports
of Clinical Trials
Trial Registration
Cover letter In accordance with the International Committee of Medical
A cover letter is your opportunity to introduce your study Journal Editors’ Recommendations for the Conduct,
to the editor, highlighting the most important findings and Reporting, Editing, and Publication of Scholarly Work
Find out more about reporting novelty. Please include the following information: in Medical Journals, The BMJ will not consider reports of
trial registration
clinical trials unless they were registered prospectively
All recommended trial registration
reporting guidance is available • Details of previous publications from the same study before recruitment of any participants. For trials that
to view on our Instructions for — including in scientific abstracts or partial reports by started before 1 July 2005 retrospective registration will be
Authors page. the media at scientific meetings and in foreign language acceptable, but only if completed before submission of the
journals. manuscript to the journal. The trial registration number
and name of register should be included at the end of the
• Details of any previous publication of the same study structured abstract. The BMJ accepts registration in any
in electronic form, including on any preprint server. The registry that is a primary register of the WHO International
BMJ does not consider posting of protocols and results Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.
in clinical trials registries to be prior publication, but gov, which is a data provider to the WHO ICTRP.
The Patient and Public Involvement statement should provide a brief response to the following questions, tailored as
appropriate for the study design reported:
• At what stage in the research process were patients/public first involved in the research and how?
• How were the research question(s) and outcome measures developed and informed by their priorities, experience, and
preferences?
• How were patients/public involved in the design of this study?
• How were they involved in the recruitment to and conduct of the study?
• Were they asked to assess the burden of the intervention and time required to participate in the research?
In addition to considering the points above we advise authors to look at guidance for best reporting of patient and public
involvement as set out in the GRIPP2 reporting checklist. Even if patients were not involved in the study described, we
suggest that you consider enlisting their help in disseminating the research findings.
If information detailing whether there was patient and public involvement, or not, is missing in the submitted manuscript we
will request authors to provide it. Where they have been involved we consider it good practice for authors to name and thank
them in the contributorship statement after seeking their permission to do so; and to clearly identify them as patient/public
contributors. When they have contributed substantially and meet authorship criteria they should be invited to coauthor
the manuscript. Please note also note that it’s The BMJ policy to send relevant research papers for review by patient
reviewers alongside academic peer reviewers.
Ethics approval:
All research studies published in The BMJ should be morally acceptable, and must follow the World Medical Association’s
Declaration of Helsinki. To ensure this, we aim to appraise the ethical aspects of any submitted work that involves human
participants, whatever descriptive label is given to that work including research, audit, and sometimes debate. This policy
also applies on the very rare occasions that we publish work done with animal participants. The manuscript must include
a statement that the study obtained ethics approval (or a statement that it was not required), including the name of the
ethics committee(s) or institutional review board(s), the number/ID of the approval(s), and a statement that participants
gave informed consent before taking part.
Transparency statement:
Please include in your manuscript a transparency declaration: a statement that the lead author (the manuscript’s guarantor)
affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important
aspects of the study have been omitted; and that any discrepancies from the study as originally planned (and, if relevant,
registered) have been explained. The BMJ is committed to making the editorial process transparent and ethical. The BMJ’s
transparency policies are accessible from this link.
If you are submitting an original article reporting an industry sponsored clinical trial, postmarketing study, or other
observational study please follow the guidelines on good publication practice (GPP2) and on properly reporting the role
of professional medical writers. Another resource, the “Authors’ Submission Toolkit: A practical guide to getting your
research published” summarises general tips and best practices to increase awareness of journals’ editorial requirements,
how to choose the right journal, submission processes, publication ethics, peer review, and effective communication with
editors — much of which has traditionally been seen as mysterious to authors.
The BMJ will not consider for publication any study that is partly or wholly funded by the tobacco industry, as explained in this
editorial.
Data sharing with Dryad Data sharing requesting data to send a rapid response to thebmj.com,
The BMJ has partnered with the We require a data sharing statement for all research describing what they are looking for. If the request is refused
Dryad digital repository datadryad.
org to make open deposition easy papers. For papers that do not report a trial, we do not we will ask the authors of the paper to explain why.
and to allow direct linkage by doi require that authors agree to share the data, just that they
from the dataset to The BMJ's article will say whether they will. In addition, we will follow the new ICMJE data sharing
and back (for The BMJ's articles'
datasets see here) policy that goes into place on July 1, 2018 (see editorial):
For reports of clinical trials, we ask that the authors manuscripts submitted to ICMJE journals that report
commit to making the relevant anonymised patient level the results of clinical trials must contain a data sharing
data available on reasonable request (see editorial). This statement that indicates whether individual de-identified
policy applies to any research article that reports the main participant data (including data dictionaries) will be
endpoints of a randomised controlled trial of one or more shared; what data in particular will be shared; whether
drugs or medical devices in current use, whether or not the additional, related documents will be available (study
trial was funded by industry. protocol, statistical analysis plan, etc); when the data will
become available and for how long; by what access criteria
"Relevant data" encompasses all anonymised data on data will be shared (including with whom, for what types of
individual patients on which the analysis, results, and analyses, and by what mechanism). Clinical trials that begin
conclusions reported in the paper are based. As for enrolling participants on or after January 1, 2019 must also
"reasonable request," The BMJ is not in a position to include a data sharing plan in the trial’s registration. If the
adjudicate, but we will expect requesters to submit a data sharing plan changes after registration this should be
protocol for their re-analysis to the authors and to commit reflected in the statement submitted and published with the
to making their results public. We will encourage those manuscript, and updated in the registry record.
4.2 RESEARCH METHODS AND REPORTING use specific methods under discussion can be included as
additional boxes. If appropriate, include a box of linked infor-
The BMJ is also interested in original studies on research mation such as website urls for those who want to pursue the
methodology, research reporting, peer review, and subject in more depth.
evidence based medicine. The same criteria apply to
these as to all the other types of research we consider. Web extras
We will give priority to studies that will be relevant and We may be able to publish on bmj.com some additional
interesting to enough of our readers (not only to editors, boxes, figures, and references. Please included these as a web
statisticians, and other experts on methodology) and reference list in the main article file. You may also include
will help them make better decisions when conducting suggestions for linked podcasts or video clips, as appropriate.
research; searching for evidence; or using research
evidence in their practice, their teaching, or their Contributors and sources
learning. We also publish essays about designing, We ask for a 100—150 word supplementary paragraph
conducting, and reporting research, in our research (excluded from word count) to explain the article’s prove-
methods and reporting section. nance. It should include the relevant experience and exper-
tise of each author, his or her contribution to the paper, and
We are willing to consider papers that present new or the sources of information used to prepare it. One author
updated research reporting guidelines, but only if the must be nominated as the guarantor of the article. Include
guideline pertains to a study type that we publish in a statement of sources and selection criteria.
The BMJ. The checklist itself must be included as part
of the paper. We prefer to be the only journal publishing Key messages box
the guideline, but under some circumstances we will Include up to four sentences, in the form of short bullet
consider copublication with up to two other journals. points, highlighting the article’s main points.
Research Methods and Reporting articles should have the RESEARCH METHODS AND REPORTING — OPEN ACCESS
elements below. Research Methods and Reporting articles are not
published as Open Access by default.
Word count and style
We do not set fixed word count limits for RMR articles. None- If you would like your article to be published with an Open
theless, we ask you to make your article concise and make Access licence, we recommend requesting this directly on
every word count. For some submissions this might be pub- submission. Standard BMJ Open Access fees apply to all
lished in full on bmj.com with a shorter version or abstract Research Methods and Reporting articles published with
in the print BMJ. an Open Access licence. Find out more about our Open
Access policy here.
Title and abstract
A short title is followed by an 100—150 word italicised sum-
mary (the standfirst) which encapsulates the article’s central
message.
Introduction
Articles should begin with a brief paragraph that captures
readers’ attention and explains the aim of the piece.
Text
The body of the text should be broken up under subheadings
that provide a logical narrative structure. Avoid acronyms
and abbreviations unless they are universally recognised
e.g. DNA. The evidence on which key statements are based
should be explicit and referenced, and the strength of the
evidence (published trials, systematic reviews, observational
studies, expert opinion etc.) addressed.
Please provide two or three sentences (no more than 100 words) explaining the picture, and please send us the signed consent to publication from the
patient. Please make sure that the text includes all authors’ names together with their job titles and addresses (including departments’ and hospitals’
names) at the time the patient was seen, and the email address of the corresponding author. We also need to recieve statements of competing interests
and copyright/licence.
NB: Minerva pictures/articles are not indexed in PubMed.
Endgames The BMJ does not publish standard case reports. We do, however, publish Writing up a Case Review: Varies — authors
articles about real cases if they are suitable for presentation in specific Case Review articles must include a short vignette and 3 questions with short will be contacted
educational formats. These include Endgames case reviews and picture answers for The BMJ’s print edition and three longer discussions/answers for by our editors
quizzes. bmj.com . Please ensure all information required to answer the questions is prior after forms
contained in the vignette. We encourage accompanying clinical illustrations. have been
Endgames is designed to help doctors across all levels and specialties Please cover important points for generalists including red flags and advice considered
test their knowledge and reflect on their practice for continuing medical for patients.
education. Endgames articles are based on genuine clinical scenarios. The discussions/long answers must be evidence based with relevant
We only consider common topics rather than clinical rarities (or very rare citations.
complications of common diseases, which may be more suitable for A maximum of four authors is allowed for each Case Review article, and each
BMJ Case Reports journal.) We consider hospital and community based author should have no more than 2 articles under consideration at any one
scenarios providing the content is generalisable. We do not publish articles time.
if the patient management is controversial.
Writing up a Spot Diagnosis:
At least one author must be a specialist (consultant, post CCT, or equivalent) Spot Diagnosis articles must based on a clinical image that is distinctive of
in a field relevant to the topic and all authors must satisfy our strict a particular condition. A short vignette should accompany the image and
competing interest criteria. The online competing interests form must be there should be one question relevant to the image and diagnosis. The article
completed by all authors prior to submission. To avoid duplication of large should include no more than two learning points as a take home message for
paragraphs of text from textbooks or journals, we ask authors to provide a readers. A maximum of two authors is allowed for each Spot Diagnosis article,
signed originality of work attestation form. and each author should have no more than 2 articles under consideration at
any one time.
Which cases are suitable?
Please check our archive as we do not repeat topics within 3 years. We only consider common topics rather than clinical rarities and are unlikely to accept
an article if the prevalence of the condition is less than 1/100 000 in the population. This includes very rare complications of common diseases, which may
be more suitable for BMJ’s Case Reports journal. We consider hospital and community based scenarios providing the content is generalisable. We do not
publish articles if the patient management is controversial. If you wish to inquire about the suitability of a particular case for Endgames please complete
this form.
At least one other box or table and at least one figure or image that complement the text of the article.